4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-24-016240
Chief Scientific Officer sold 21,078 shares at an average $57.33 ($1,208,418)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Reich Kristian · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-20 | Sale : show line 1 in the form 10b5-1 | −10,000 | $57.45 | $574,500 | 2,987,483 | I |
| 2024-02-20 | Sale : show line 2 in the form 10b5-1 | −10,000 | $57.43 | $574,300 | 100,071 | D |
| 2024-02-21 | Sale : show line 3 in the form 10b5-1 | −509 | $55.31 | $28,153 | 2,986,974 | I |
| 2024-02-21 | Sale : show line 4 in the form 10b5-1 | −569 | $55.30 | $31,466 | 99,502 | D |
| Open-market sales · 21,078 sh · avg $57.33 · $1,208,418 | ||||||
Loading xslF345X05/ownership.xml…